Trouble Brews For Chinese Chipmakers As US Senators Propose Harsher Measures

U.S. Senate Majority Leader Chuck Schumer and Republican Senator John Cornyn are lobbying hard for a ban on…
  • U.S. Senate Majority Leader Chuck Schumer and Republican Senator John Cornyn are lobbying hard for a ban on government business with Chinese chipmakers, Politico reports.
  • The senators want to get their amendment which blocks federal access to semiconductor products and services made by Chinese firms, into the final version of this year’s National Defense Authorization Act (NDAA).
  • The measure would broaden provisions in Section 889 that already prohibit government agencies from doing business with Chinese telecommunications companies or contractors who use their technologies.
  • Also Read: Alibaba Comes Back Strong Against US Sanctions; To Power 20% Operations By In-House CPUs By 2025
  • Section 889 mainly targets Chinese conglomerates like Huawei or ZTE. 
  • But the Schumer-Cornyn measure would grow the targeted list to include the Semiconductor Manufacturing International Corp.Yangtze Memory Technologies Corp., and ChangXin Memory Technologies.
  • YMTC has come under increased scrutiny for violating export controls by continuing to supply chips to Huawei Technologies Co, Ltd and aiming to do business with Apple Inc (NASDAQ:AAPL).
  • Alibaba Group Holding Limited (NYSE: BABA) and start-up Biren Technology tweaked their most advanced chip designs to reduce processing speeds and bypass U.S.-imposed sanctions.
  • Alibaba, Biren, and other Chinese design houses have spent years and millions of dollars creating the blueprints for advanced processors to power the country’s next generation of supercomputers, artificial intelligence algorithms, and data centers.
  • Photo: Body Stock and Dragon Claws by Shutterstock
Total
0
Shares
Related Posts
Read More

Veterans With ALS Who Support Co’s Request For The FDA To Hold A Public Advisory Committee Meeting To Engage In Scientific Discourse About The “Clinically Meaningful” Evidence Supporting FDA’s Approval Of A Mesenchymal Stem Cell Therapy, NurOwn

Veterans have a Significantly Increased Risk of 100% Fatal ALS, Caused by their Service for our Country FDA Advisory Committee Meeting is Essential to Allow Veterans' Voices to be Heard about Need for

BCLI